Mayer Brown represented GW Pharmaceuticals plc, a biopharmaceutical company, in a $206.08 million US public offering of American Depositary Shares on the Nasdaq Global Market led by Morgan Stanley, BofA Merrill Lynch and Cowen and Company.

The Mayer Brown team was led by Corporate & Securities partner David Bakst (New York) and included: Corporate & Securities partner Richard Smith (London) and associates George Rudy, Kelly Camp (both New York) and Vivian Chiu (London); Tax Transactions & Consulting partners Jason Bazar (New York) and James Hill (London), senior associate Benjamin Fryer (London) and associate Jared Goldberger (New York); and Intellectual Property – partner Richard Assmus and counsel Jonathan Kim (both Chicago).